Amicus Therapeutics Inc (NASDAQ:FOLD)

11.39
Delayed Data
As of May 22
 0.00 / 0.00%
Today’s Change
2.01
Today|||52-Week Range
13.20
+36.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues475.0K293.0K0.000.00
 
 
 
Depreciation And Amortization396.0K375.0K363.0K508.0K
 
 
 
 
 
 
Operating ExpensesGross Income-----363.0K-508.0K
 
 
 
General Expenses14.7M17.3M21.1M22.5M
 
 
 
 
 
Research And Development10.0M12.0M15.6M16.1M
 
 
 
 
 
Total Operating Expenses15.1M17.7M21.5M23.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.7M-17.4M-21.5M-23.0M
 
 
 
 
 
Extraordinary Credit386.0K600.0K----
 
 
 
Extraordinary Charge-10.0K-26.0K-511.0K-1.0M
 
 
 
 
 
Interest Expense On Debt374.0K377.0K378.0K372.0K
 
 
 
 
 
Other Expenses0.000.00-47.0K-29.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.6M-17.1M-22.3M-24.3M
 
 
 
 
 
Income Taxes0.000.00-1.1M--
 
 
Net Income-14.6M-17.1M-21.2M-24.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS67.2M78.9M87.0M95.7M
 
 
 
 
 
Shares To Calculate EPS Diluted67.2M78.9M87.0M95.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.22-$0.24-$0.25
 
 
 
 
 
EPS Diluted-$0.22-$0.22-$0.24-$0.25
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account